Regenesome is focused on addressing the challenges of aging through innovative biotechnological solutions. The company is engaged in the development of aging care products, including supplements and foods that leverage exosome technology. This approach is rooted in scientific research and aims to enhance human healthspan by utilizing insights gained from epigenetic studies and exosome analysis. Regenesome collaborates with academic institutions, such as Gifu University, to advance its research and has filed patents related to epigenetic clocks, indicating a commitment to cutting-edge scientific exploration.

In addition to its product development, Regenesome is involved in broader initiatives aimed at extending human healthspan, including participation in global contests like the XPRIZE Healthspan. The company is also establishing a new laboratory, the Takanawa Longevity Lab, to further its research efforts. By combining knowledge from space science and life sciences, Regenesome aims to create practical applications for aging prevention technologies that can benefit both terrestrial and extraterrestrial environments, ultimately contributing to a society where aging is no longer a burden.

Japan

Regenesome aims to provide new solutions for anti-aging and regenerative medicine by utilizing nanoparticles such as exosomes. In May 2025, the company opened its headquarters and research institute, Takanawa Longevity Lab, at LiSH to accelerate business development and research and development. In the future, the company aims to develop medical technology and establish new solutions in the field of space medicine, thereby extending healthy lifespans and contributing to humanity's advance into space.

Regenesome

Company Details